iHEA

September 01, 2006

Better But Not Well: Mental Health Policy in the United States since 1950

Authors: Richard G. Frank and Sherry A. Glied (Foreword by Rosalynn Carter)

Publisher: John Hopkins University Press

Price: $39.95 hardcover; 208 pp. 13 line illustrations (30 ctn qty)
ISBN: 0-8018-8442-X

Price: $21.95 paperback; 208 pp. 13 line illustrations (38 ctn qty)
ISBN: 0-8018-8443-8

Description: The past half-century has been marked by major changes in the treatment of mental illness: important advances in understanding mental illnesses, increases in spending on mental health care and support of people with mental illnesses, and the availability of new medications that are easier for the patient to tolerate. Although these changes have made things better for those who have mental illness, they are not quite enough.

In Better But Not Well , Richard G. Frank and Sherry A. Glied examine the well-being of people with mental illness in the United States over the past fifty years, addressing issues such as economics, treatment, standards of living, rights, and stigma. Marshaling a range of new empirical evidence, they first argue that people with mental illness—severe and persistent disorders as well as less serious mental health conditions—are faring better today than in the past. Improvements have come about for unheralded and unexpected reasons. Rather than being a result of more effective mental health treatments, progress has come from the growth of private health insurance and of mainstream social programs—such as Medicaid, Supplemental Security Income, housing vouchers, and food stamps—and the development of new treatments that are easier for patients to tolerate and for physicians to manage.

The authors remind us that, despite the progress that has been made, this disadvantaged group remains worse off than most others in society. The “mainstreaming” of persons with mental illness has left a policy void, where governmental institutions responsible for meeting the needs of mental health patients lack resources and programmatic authority. To fill this void, Frank and Glied suggest that institutional resources be applied systematically and routinely to examine and address how federal and state programs affect the well-being of people with mental illness.

Reviews

“By pulling information from a wide variety of sources, these authors provide a fresh and optimistic look on improvements in the well-being of people with mental illness. A major contribution to the field.”
— Steven Sharfstein, President and CEO of the Sheppard Pratt Health System

“An important and provocative addition to the literature dealing with health policy.”
— Gerald N. Grob, Ph.D., Institute for Health, Health Care Policy, and Aging Research, Rutgers University, author of The Deadly Truth

“Professors Frank and Glied offer a broad-based and candid assessment of the evolution of mental health care in the United States and of how the well-being of people touched by mental health problems changed during the last half of the twentieth century.”
— Rosalynn Carter, from the Foreword

Author Information

Richard G. Frank is the Morris Professor of Health Economics at Harvard University Medical School and a research associate at the National Bureau of Economic Research. Sherry A. Glied is a professor in and chair of the Department of Health Policy and Management at the Mailman School of Public Health, Columbia University.

Website

September 01, 2006: Policy

March 30, 2006

Health Financing Revisited: A Practitioner's Guide

Authors: Pablo Gottret, George Schieber
Publisher: World Bank Publications
Published: March 2006
ISBN: 0-8213-6585-1
Price: $40 Paperback

2006 English Paperback 336pp 6 x 9.25

This overview of health financing tools, policies and trends—with a particular focus on challenges facing developing countries—provides the basis for effective policy-making. Analyzing the current global environment, the book discusses health financing goals in the context of both the underlying health, demographic, social, economic, political and demographic analytics as well as the institutional realities faced by developing countries, and assesses policy options in the context of global evidence, the international aid architecture, cross-sectoral interactions, and countries’ macroeconomic frameworks and overall development plans.

Order a copy of this book online

All health financing systems try to follow three basic principles of public finance:

1. Raise enough revenues to provide individuals with basic packages of essential services and financial protection against catastrophic medical expenses caused by illness and injury in an equitable, efficient and financially sustainable manner.
2. Manage these revenues to pool health risks equitably and efficiently.
3. Ensure the purchase of health services in ways that are allocatively and technically efficient.

Health Financing Revisited: A Practitioner’s Guide addresses the major changes in global health policy, financing modalities, and financing intruments that have occurred over the past 10 years resulting from the global focus on poverty reduction, new global health threats from HIV/AIDS, SARS, and avian influenza, and the international community’s adotption of the Millennium Development Goals (MDG). As a result of these factors, global health policy has now become a foreign policy, national security, and humanitarian issue for all countries, and significant amounts of increased resources for development assistance, much of it targeted to health, have been forthcoming.

This report assesses health financing policies from the perspectives of these basic principles and evaluates them for their ability to improve health outcomes, provide financial protection, and ensure consumer satisfaction - in a equitable, efficient, and financially sustainable manner. It is intended to equip policy-makers at global and country levels with the tools for navigating this extremely complex domain by providing an overview of health financing policy in developing countries and is a primer on major health financing and fiscal issues. It is intended to assist policy-makers and other stakeholders in the design, implementation, and evaluation of effective health financing reforms.

Download Chapters in PDF Format

Table of Contents:

• Table of Contents, Foreword & Achnowledgements
• Overview
• Chapter 1: Health transitions, disease burdens, and health expenditure patterns
• Chapter 2: Collecting revenue, pooling risk, and purchasing services
• Chapter 3: Risk pooling mechansims
• Chapter 4: External assistance for health
• Chapter 5: Improving health outcomes
• Chapter 6: Increasing the efficiency of government spending
• Chapter 7: Financing health in low-income countries
• Chapter 8: Financing health in middle-income countries
• Chapter 9: Financing health in high-income countries

March 30, 2006: Policy

February 01, 2005

The Public Financing of Pharmaceuticals. An economic approach

Editor: Jaume Puig-Junoy
ISBN: 1 84542 088 8
Publisher: Edward Elgar Publishing Limited
Price: £65.00 (web price £58.50)

February 2005, 272 pp, Hardback

This book provides a complete approach to the economics of financing medicines and policy implications for the efficiency and equity of health systems. In all health systems with majority public financing, pharmaceutical reimbursement is one of the key factors in policies of change and transformation of health services in order to face the future with guarantees of financial sustainability.

The initial chapters seek to answer questions about the efficiency with which the public sector intervenes in the pharmaceutical industry: Is the present system of drug patents efficient and fair? What would be the best way to control drug prices? Is it possible to encourage competition in this market for the patients’ benefit? The remainder of the book provides evidence on the impact of instruments and policies aimed at rationalising and controlling pharmaceutical expenditure: What can we expect from the application of reference pricing systems? When, how and where should the user be made to share the cost of medicines? What economic and non-economic incentives should be applied to drug prescription?

Jaume Puig-Junoy has performed an invaluable task in creating a cohesive, and analytically rigorous book of specially commissioned chapters on this pertinent topic.

The Public Financing of Pharmaceuticals will appeal to academics and researchers involved in public finance, health policy, health economics, industrial organisation and the pharmaceutical markets in Europe and in the US, where there is increasing public interest in drug coverage. The book is also intended for a wide variety of professionals in the health industries, and policymakers.

Contents

Introduction Public Pharmaceutical Expenditure

1. Incentives for Innovation in the Pharmaceutical Market
2. Price Regulation Systems in the Pharmaceutical Market
3. Regulation and Competition in Pharmaceutical Markets
4. Mechanisms to Encourage Price Competition in the Pharmaceutical Market and their Effects on Efficiency and Welfare
5. Reference Pricing as a Pharmaceutical Reimbursement Mechanism
6. Insurance in Public Financing of Pharmaceuticals
7. Economic Evaluation and Pharmaceutical Policy
8. Prescriber Incentives
9. Some Economic Considerations Regarding Pharmaceutical Expenditure in Spain and its Financing
10. Review of Economic Studies of the Pharmaceutical Industry and Pharmaceuticals Published Over the Last 20 Years by Spanish Economists

Appendix

Contributors include: X. Badía Llach, J.R. Borrell Arqué, M. Cabañas Sáenz, L. Cabiedes Miragaya, A. Costas Comesaña, J. Darbà Coll, B. González López-Valcárcel, R. González Pérez, P. Ibern Regàs, F. Lobo, G. López-Casasnovas, R. Nonell Torres, V. Ortún Rubio, J.L. Pinto Prades, J. Puig-Junoy, J. Rovira Forns.

February 01, 2005: Policy

December 01, 2004

Health Policy and Economics: Opportunities and Challenges

Authors: Peter Smith, Laura Ginnelly, Mark Sculpher
ISBN: 0335215742
Publisher: McGraw Hill Education Europe

In its brief lifetime, health economics has made major contributions to the development of health policy in many countries. This book describes those successes, but it also looks forward to the major contributions that health economics can bring to bear on emerging policy issues in health and health care in the future.

The book originates from a conference to celebrate twenty years of research at the Centre for Health Economics at the University of York. It contains contributions from many of the internationally recognized researchers at the Centre and their colleagues, and seeks to address generic policy issues confronting health systems across the developed world.

The coverage progresses from micro, patient level issues to macro, whole system issues. Topics covered include: determining the most cost-effective treatment to offer patients; policy issues of fairness and the distribution of health within the population; regulatory issues, in the form of performance measurement and incentives for organizations and individual workers; distributing revenue and capital finances; and the implications of simultaneously increased decentralization and increased internationalization of health systems.

Contributors: Paul Kind; John E Brazier; Mark J Sculpher; Karl P Claxton; Ron L. Akehurst; Alan H Williams; Paul Dolan; Aki Tsuchiya; Andrew M Jones; Nigel Rice; Maria Goddard; Hugh Gravelle; Richard Cookson; Rowena Jacobs; Andrew D Street; Alan K Maynard; Karen E Bloor; Matthew Sutton; Diane A Dawson; Sean Boyle; Peter C Smith; Rosella Levaggi; Mike Drummond and Adrian Towse.

£22.99, 288 pages

For ordering information go to McGraw Hill

CONTENTS

Introduction

CHAPTER 1: Valuing health outcomes: changing requirements and differing perspectives

CHAPTER 2: Its Just Evaluation for Decision Making: Recent Developments in, and Challenges for, Cost-Effectiveness Research

CHAPTER 3: Incorporating citizens' preferences about fairness into health policy

CHAPTER 4: Socioeconomic inequality and mobility in health

CHAPTER 5: Regulating health care markets

CHAPTER 6: Measuring the performance of health systems and organizations

CHAPTER 7: Regulating labour markets

CHAPTER 8: Formula funding of health purchasers

CHAPTER 9: Capital financing

CHAPTER 10: Decentralization in health care: lessons from public economics

CHAPTER 11: European integration and the economics of health care

Conclusions, Opportunities and Challenges

December 01, 2004: Policy

October 24, 2004

Almost Home: Reforming Home and Community Care in Ontario

Authors: Patricia Baranek, Raisa Deber, A. Paul Williams
ISBN: 0-8020-8965-8 $65.00 - Cloth
ISBN: 0-8020-8639-X $29.95 - Paper
Publisher: University of Toronto Press

Almost Home deals with the shift of care from the Medicare 'mainstream' of physician and hospital care, to home and community. It notes that this shift is not only a change in the site of care but also a change in the applicable rules. Care in the community is no longer bound by the rules and conditions of the Canada Health Act.

The policy questions discussed in Almost Home reflect the change that is reshaping Canadian health care policy and politics. Using document analysis, interviews with government officials, and other key stakeholders in the policy community, the authors analyze the policy content and process of five different attempts to reform home and community care in Ontario between 1985 and 1996, as introduced by Liberal, New Democratic, and Conservative governments.

Ordering Information

October 24, 2004: Policy

October 01, 2004

Activity Base Funding for Hospitals: English Policy, International Experience

Editors: J Sussex, A Street
ISBN: 1 899040 08 0 Published: October 2004

The NHS in England is following the US, Australia and many countries in Europe in introducing a system of paying hospitals and other providers on the basis of the work they do. Providers receive a fixed payment -- the national tariff -- for each type of patient treated. Termed "payment by results" by the English Department of Health, the policy rewards providers for volumes of work adjusted for differences in case mix. This book draws lessons from international experience and research and is based on the presentations and discussions at a conference organised by the Office of Health Economics and the University of York Centre for Health Economics and held at The Commonwealth Club, London, on 31st March 2004.

To order contact Liz Aulsford (44-207-930-9203) or visit the OHE Web Site
Price: GBP £12.50

October 01, 2004: Policy

State Health Insurance Market Reform: Toward Inclusive andSustainable Health Insurance Markets

Editors: Alan C. Monheit and Joel C. Cantor
ISBN: 0-415-70035-3
Publisher: Routledge International Studies in Health Economics

Availability: October 2004

Description: Since the late 1980s, many US states have sought to incrementally reform their health insurance markets. The intent of such reform has been quite straightforward: to ensure access to affordable health insurance by addressing insurer practices perceived to be exclusionary. In the light of this, a compelling public policy issue is whether these efforts to address disparities in the population's access to health insurance have been successful or yielded unintended consequences.

This volume provides a critical assessment of the current state of knowledge on insurance market reform that is accessible to both policymakers and researchers. The contributions provide a critical evaluation of empirical research findings, applied methodologies, and policy implications associated with state reform of small-group and individual insurance markets.

With contributions from internationally respected health economists, as well as industry, regulatory, and consumer representatives, this book will prove to be a useful read for all those with an interest in the economics of health care.

More information on the book may be obtained at Routledge

TABLE OF CONTENTS

Preface
Acknowledgements
1. Introduction: Alan C. Monheit and Joel C. Cantor
PART I. Critical Evaluation of Research Findings
2. What Have We Learned from Research on Small-Group Market Reform? Kosali Ilayperuma Simon
3. What Have We Learned from Research on Individual Market Reform? Deborah Chollet
PART II. Responses to Findings on Insurance Market Reform
4. What Can We Learn from the Research on Insurance Market Reform? Thomas C. Buchmueller
5. A Critical Assessment of Research on Insurance Market Reform: Barbara Steinberg Schone
PART III. Perspectives from the Field: How Can Access to Affordable Coverage be Sustained?
6. An Insurance Executive Reflects on Insurance Market Reform: Sanford B. Herman
7. An Insurance Commissioner Reflects on Insurance Market Reform: Steven B. Larsen
8. Can Access to Affordable Health Insurance be Sustained? Karen Pollitz
PART IV. Reforming Insurance Market Reform: What are the Possibilities? What are the Alternatives?
9. How Can Reform Work Better? M. Susan Marquis
10. Improving State Insurance Market Reform: What's Left to Try? Len M. Nichols
11. Insurance Market Reform: When, How, Why? Katherine Swartz
12. Conclusions: Alan. C. Monheit and Joel C. Cantor

October 01, 2004: Policy

Using Cost-Effectiveness Analysis to Improve Health Care: Peter J. Neumann

Author: Peter J. Neumann
ISBN: 0195171861
Publisher: Oxford University Press
Discounted Price: $26.25

Oct 2004, Hardback

Oxford University Press is proud to present: Using Cost-Effectiveness Analysis to Improve Health Care Opportunities and Barriers by Peter J. Neumann, Associate Professor of Policy and Decision Science in the Department of Health Policy and Management, Harvard School of Public Health.

As health costs in the U.S. soar past $1.5 trillion, it is widely agreed that we could do better by using cost-effective analysis (CEA) to help determine which health care services are most worthwhile. American policy makers, however, have largely avoided using CEA, and researchers have devoted little attention to understanding why this is so. By considering the economic, social, legal, and ethical factors that contribute to the situation, and how they can be negotiated in the future, this book offers a unique perspective. It traces the roots of CEA in health and medicine, describes its promise for rational resource allocation, and discusses the nature of the opposition to it, using Medicare and the Oregon health plans as examples.

The book seeks to find common ground and practical solutions analyzing the prospects for change and presents a roadmap for getting there. It offers pragmatic advice for cost-effectiveness analysts, and also offers advice for policy makers and politicians, including lessons from Europe, Canada, and Australia, and underlines the need for leadership to establish the conditions for change. Order by phone 1-800-451-7556 or http://www.oup.com/us/

USE PROMOTION CODE 24680

October 01, 2004: Policy

August 01, 2004

Economics of Health Care Financing: The Visible Hand

Authors: Cam Donaldson, Karen Gerard, Craig Mitton, Stephen Jan and Virginia Wiseman
ISBN: 0-333-98431-5
Publisher: Palgrave MacMillan

The new edition of this popular text examines the economics of health care systems in a manner that is non-technical, and so accessible for economists and non-economists alike. It is very timely and includes the latest research into the implications of health care reforms across a number of different countries and systems.

August 2004 296 pages 234x156mm
Second edition

Web Site

August 01, 2004: Policy

Economics of Health Care Financing: The Visible Hand 2nd edition

Authors: Cam Donaldson and Karen Gerard with Craig Mitton, Stephen Jan & Virginia Wiseman
ISBN: 0333984315
Publisher: Palgrave Orders
Price: £24.99

August 2004, 296 pp, Paperback (2nd Ed.)

‘Economics of Health Care Financing’ takes a fresh look at the key global health care reforms of the last 20 years. The authors draw conclusions based on the available evidence about whether governments should intervene in health care, about who is best placed to mediate on health care financing issues and about the challenges the future presents. The book has international appeal as an increasing number of countries are introducing health care reforms. The inspiring new empirical research that has taken place since the first edition is documented in the second part of the book, making it essential reading for health care policy makers and students of health care reform throughout the world.

To order your copy visit http://www.palgrave.com/ or write to us at

Palgrave Orders,
Houndmills, Brunel Road,
Basingstoke, UK RG21 6XS

telephone +44(0)1256 302866.

August 01, 2004: Policy

What Could be Nicer Than NICE?

Author: A Williams
ISBN: 1 899040 03 X
Publisher: Office for Health Economics

Published: August 2004

This book provides the full text of Professor Alan Williams' OHE Annual Lecture 2004. He discusses a number of controversial issues about the role of the National Institute for Clinical Excellence (NICE). He argues that: NICE is not a quasi-judicial authority dispensing justice, as commonly believed, but rather is a watchdog protecting the interests of the general public. The £30,000 per QALY threshold in NICE's technology appraisals needs further investigation given that in the UK average national income per person is £18,000, which provides for all the needs of an average citizen (food, shelter, transport, education) in each year. NICE's clinical guidelines need strengthening with decision-analytic expertise, mapping the whole health care territory in a systematic way. This should include information on everyone who enters the system even if they choose to opt out of the NHS. NICE's Clinical Guidelines, and not just their technology appraisals, should be based on cost-effectiveness criteria, including QALYs, so that NICE can make comparative judgements across diseases and so that the clinical and technology appraisal cost-effectiveness benchmarks are consistent

Price: GBP £10.00

To order contact Liz Aulsford (44-207-930-9203) or visit the OHE Web Site

August 01, 2004: Policy

July 01, 2004

How much should we spend on the NHS? Issues and challenges arising from the Wanless Review of future health care spending

Editors: John Appleby, Nancy Devlin, Diane Dawson
ISBN: 1 899040 87 0
Publisher: Office for Health Economics, King's Fund, York University Centre for Health Economics

Price: £12.50

The Wanless Report "Securing Our Future Health" published in 2002 was ground-breaking. It recommended unprecedented spending increases for the NHS of around 7.5% annually in real terms over the next five years. So far, in each subsequent budget the Chancellor has followed these recommendations.

"Securing Our Future Health" is based on some key assumptions, namely that the government can manage the UK's demand for health care encouraging the public to take an active role in preventing ill health; that healthy lifestyles will lead to an overall reduction in the demand for NHS services; productivity in the NHS can improve by 2.5% per annum, and population ageing will primarily affect health care spending at the end of life.

This monograph challenges these and other underlying assumptions, and questions how we can measure progress, and how critical these are to future spending projections. Notably it asks when the models developed by Wanless and his team will be open to public scrutiny, as they are for instance in the US, given its use by government to guide health care expenditure in this country and that Wanless suggested this review exercise be repeated regularly to update and refine the assumptions and knowledge underpinning the spending review.

To order got to OHE

July 01, 2004: Policy

Evaluating the Healthcare System: Effectiveness, Efficiency, and Equity, Third Edition

Authors: Lu Ann Aday, Charles E. Begley, David R. Lairson, Rajesh Balkrishnan
ISBN: 1-56793-222-3
Publisher: Health Administration Press

The book provides an excellent framework for understanding and evaluating healthcare systems and change. By focusing separately on the key system outcomes (effectiveness, efficiency, and equity) and carefully laying out relevant concepts before applying them to major policy issues, the authors provide an unusually thorough treatment of the field of health services research.
-Thomas Rice, Ph.D., Professor of Health Services
University of California at Los Angeles School of Public Health

This upcoming third edition defines and illustrates the measurement and relevance of effectiveness, efficiency, and equity as criteria for evaluating healthcare system performance. Specific examples of the application of health services research in addressing contemporary health policy problems at the national, state, and local level are presented.

This new edition will include a significant amount of new material. In particular, the book will draw upon a growing body of research on the social and economic determinants of population health, and explore the distinct and complementary roles of health services and public health research and policy in improving the health of individuals and communities.

An important healthcare and public health problem area woven throughout the book in demonstrating the effectiveness, efficiency, and equity concepts in the context of these issues is breast and cervical cancer prevention and treatment and related cancer morbidity and mortality outcomes. This example provides a useful opportunity to explore the medical and non-medical predictors of health and healthcare disparities, the role of primary versus secondary prevention, and the utility of the effectiveness, efficiency, and equity benchmarks in guiding the design of state and federal policy to ameliorate disparities.

For more information go to: HAP

Hardbound, approximately 350 pp
Order code: WWW1-2013
Price: $72.00

Table of Contents

• List of Figures
• List of Tables
• Foreword
• Preface
• Acknowledgments
• 1 Introduction to Health Services Research and Policy Analysis
• Appendix 1.1 Healthy People 2010 Leading Health Indicators
• 2 Effectiveness: Concepts and Methods
• 3 Effectiveness: Policy Strategies, Evidence, and Criteria
• 4 Efficiency: Concepts and Methods
• 5 Efficiency: Policy Strategies, Evidence, and Criteria
• 6 Equity: Concepts and Methods
• 7 Equity: Policy Strategies, Evidence, and Criteria
• Appendix 7.1 Highlights of Selected Indicators of Equity of Access to Healthcare
• 8 Integrating Health Services Research and Policy Analysis
• 9 Applying Health Services Research to Policy Analysis
• Index
• About the Authors

July 01, 2004: Policy

The Impact of Ageing on Health Care Expenditures: Impending Crisis or Misguided Concern?

Author: Meena Seshamani
ISBN: 1 899040 97 8
Publisher: Office for Health Economics

Price: £12.50

The Impact of Ageing on Health Care Expenditure: Impending Crisis or Misguided Concern? by Meena Seshamani challenges the long held belief that as the average age of populations increases so health expenditures will rise in direct proportion. Meena Seshamani's original analysis of English data shows that proximity to death is a much stronger predictor of future hospital expenditure than age alone. Additional years of life are lived in health, not disability. Only the last year or two of life significantly increases health care costs per capita, whether at 65 or 75 years of age.

The ageing of national populations has accelerated in the past few decades. It is estimated that 40 to 60% of public spending is sensitive to this changing age structure. Health care providers are concerned with the profound impact this will have on societies and economies.

Traditionally older populations are high users of health care relative to the rest of the population. Per capita expenditure for those aged 65 and over was on average 3.7 times greater than for those aged under 65 (OECD, 1993). It therefore seems logical to expect an ageing population will substantially increase health care costs. Indeed since 1970 GDP expenditure on health care among OECD countries has risen from a population-weighted average of 5.7% to 9.9%, with the UK at 6.9% and the US at 12.9%.

However using age specific expenditures for Hospital and Community Health Services (HCHS) and Family Health Services (FHS) in England and Wales, Meena Seshamani finds "a compression of morbidity" effect : people are living longer, but healthier lives. Her proximity to death findings show:

• age is insignificant in explaining health care expenditure once proximity or time to death is accounted for
• estimated increases in national hospital expenditure due to ageing can be halved
• expenditure effects of increased life span after the age of 65 are small
• most age-related increases in hospital expenditure observed to date are due to the numbers of post WWII baby boomers

For ordering information go to OHE

July 01, 2004: Policy

May 25, 2004

Implementing Primary Care Reform - Barriers and Facilitators

Editors: Ruth Wilson, S.E.D. Shortt, John Dorland
Paperback ISBN: 1-55339-040-7
Hardcover ISBN: 1-55339-041-5
Publisher: McGill-Queen's University Press

Strong primary health care systems are the foundation of effective health care. Several countries have attempted to reform primary care delivery in the past few years, with variable results. This book examines the barriers to and facilitators of primary care reform from several perspectives : political, economic, organizational, and clinical. Experience in the United Kingdom, New Zealand, and Canada is examined in detail. A compendium of reform efforts across Canada, contributed by provincial/territorial ministries of health, rounds out the book. Barbara Starfield sums up the evidence for the importance of primary care in improving health outcomes, increasing cost-effectiveness, and promoting social equity.

This book will be of interest to policy-makers, practitioners, and those interested in how change is achieved in health care systems. 280 pp.

To order:

MQUP

Direct Mail Manager
McGill-Queen's University Press
3430 McTavish Street
Montreal QC H3A 1X9 Canada
Tel: 514-398-3750
Fax: 514-398-5443
Email: McGill-Queen's University Press

May 25, 2004: Policy